11^th World Congress on Endocrinology and Metabolic Disorders September 3-4, 2018 Auckland, New Zealand

Joe Michel Chehade is a Professor of Medicine University of Florida College of Medicine, Jacksonville, Florida.He was the director of Saint Francis Medical Center, Cape Girardeau, MO. May 2000- July 2007 (ADA Accredited Program).South East Missouri Hospital, Cape Girardeau, MO. May 2000-July 2007.Board Certification: American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism Subspecialty, 1999-2009, Recertification: American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism Subspecialty, 2009-2019.He has published 2 book Book Chapters: 1.Chehade JM, Mooradian AD. Drug Therapy: Current & Emerging Therapy in Type 2 Diabetes in Diabetes in Old Age. 2001 (Second Edition) 199-214; Wiley Publication, Sinclair JA, Finucane P. 2.Chehade JM, Mooradian AD. Drug Therapy: Current & Emerging Agents for Hyperglycaemia in Diabetes in Old Age. 2009 (Third Edition) 245-264; Wiley Publication, Sinclair JA, Finucane P. He has published 30+ articles.

ongoing research 1. Chehade JM, Haas MJ. Effects of GLP-1 & Exenatide on HDL cholesterol. Amylin Pharmaceuticals, Inc. (21975$). 2. Chehade JM, Mooradian AD. Age-related changes in thyroid hormone action in humans. Dean’s Fund Faculty Research Grant. (9083$).

Dr. Joseph Fomusi Ndisang is an Associate Professor in the University of Saskatchewan College of Medicine, Department of Physiology. He received postdoctoral training in Physiology at the University of Saskatchewan College of Medicine from 2000-2005. He obtained a PhD in Pharmacology & Toxicology from the University of Florence, Italy, 2000. He obtained a Doctor of Pharmacy degree from University of Florence, Italy in 1995. He has received several distinguished awards and distinctions including: (i) Fellow of the Canadian Cardiovascular Society (FCCS) in 2016, (ii) Fellow of the American Heart Association (FAHA) in 2011; (iii) Fellow of the International College of Angiology (FICA) in 2007; (iv) Young Investigator Award by International College of Angiology (2007); (v) Young Investigator Award by the American Society of Pharmacology & Experimental Therapeutics-Division for Drug Discovery, Development & Regulatory Affairs (2005); (vi) Young Investigator Award by the Society of Experimental Biology and Medicine (2005); (vii) Caroline tum Suden/Frances A Hellebrandt Professional Opportunity Award for Meritorious Research by the American Physiological Society (2005); and (viii) Recognition Award for Meritorious Research by a Young Investigator by the American Physiological Society (2004). Top 5% of cited authors in journals of Biology and Biochemistry in 2011, by Thomson-Reuters. Currently, Dr. Ndisang is an Editor for Frontiers in Bioscience (impact factor 3.8) and Executive Guest Editor for Current Medicinal Chemistry (impact factor 3.7) He has published more than 64-full length manuscripts in peer-reviewed journals and more than 80 abstracts. Dr. Ndisang has served as external PhD examiner for several universities in Canada, has given more than 30-invited talks, and has also served as peer-reviewer for several reputed journals and granting agencies in United States, United Kingdom, Canada, New Zealand and Poland.

His research is mainly focused on investigating the role of the heme oxygenase system in hypertension, diabetes (types-1 and -2), and obesity.

Born in Germany in 1972. He completed his specialist education at Ege University. During his professional life, she worked as a psychiatric specialist in a general medical hospital, as an associate professor of psychiatry in the second largest mental health hospital in the Turkey. Since 2014, as a professor of psychiatry, she has taught at Üsküdar University and has been working with bipolar disorder in NPIstanbul Brain Hospital. Another area of interest is psychoanalytic psychotherapies.

Bipolar Disorder

Prof Muller focuses his research on the potential role of phenolic compounds in the prevention and treatment of metabolic conditions such as insulin resistance, dysbiosis, obesity and type 2 diabetes. He is also involved with a proteomics study to identify early markers for type 2 diabetes. These markers are currently being tested in human subjects. He has 2 International patents (the USA and Europe) for the prevention of diabetes and has authored and co-authored 81 peer-reviewed articles and two book chapters.

Metabolic disease (pathophysiology, prevention, and treatment), phytotherapeutics and early detection of type 2 diabetes.